May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
Differential Roles of PKC Isozymes in Mediating EGF Receptor Control of Proliferation in Human Corneal Epithelial Cells.
Author Affiliations & Notes
  • V.N. Bildin
    Biological Sciences, SUNY College of Optometry, New York, NY
  • Footnotes
    Commercial Relationships  V.N. Bildin, None.
  • Footnotes
    Support  EY04795
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 3802. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      V.N. Bildin; Differential Roles of PKC Isozymes in Mediating EGF Receptor Control of Proliferation in Human Corneal Epithelial Cells. . Invest. Ophthalmol. Vis. Sci. 2004;45(13):3802.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Activation by epidermal growth factor (EGF) of extracellular signal–regulated protein kinase (ERK1/2) and specific protein kinase C isoforms is essential for corneal epithelial mitogenesis. In the present study, we investigated, in SV40–immortalized human corneal epithelial cells (HCEC) stimulated by EGF, the differential roles of protein kinase C (PKC) isozymes in activation of the ERK pathway, Na–K–2Cl cotransporter (NKCC1) and cell proliferation. Methods: After 24 h incubation without serum, HCEC proliferation was stimulated with 5 ng/ml EGF. EGF–induced PKCs activation was inhibited by bisindolylmaleimide 1 (competitive inhibitor for the ATP–binding site) or calphostin C (competes for binding at the DAG site). Intracellular Ca2+ was chelated with BAPTA–AM. Levels of ERK1/2 and NKCC1 phosphorylation were determined by Western blotting/ECL assay 15 min after EGF exposure. Cell proliferation was determined based on measurements of 3H–thymidine incorporation after 20 h. Results: PKCs inhibition by bisindolylmaleimide 1 (0.1–1.0 µM} in serum starved HCEC produced dose–dependent increases of up to 6–fold, 80% and 25% in NKCC1, ERK1/2 phosphorylation and cell proliferation, respectively. However, there were no significant effects on NKCC1, ERK1/2 activation and the mitogenic response to EGF. On the other hand, calphostin C (1 µM) significantly decreased by more than 30% both ERK1/2 activity and cell proliferation, which completely inhibited the cell response to EGF. In addition, EGF–induced ERK1/2 activation was not very dependent on intracellular Ca2+concentration, IC50 = 200 µM BAPTA–AM. Conclusions: In serum–starved HCEC, some PKC isozyme(s) are involved in the control of cell cycle arrest and EGF–induced ERK1/2 stimulation. Its mitogenic effect is independent on the activation of novel Ca2+ independent and DAG stimulated PKC isozymes (i.e. δ, ε, &#952, η) and is accompanied by NKCC1 activation, an important component of cell volume regulation. We are currently identifying which of these PKC isozymes are involved in eliciting such effects.

Keywords: cornea: epithelium • signal transduction • growth factors/growth factor receptors 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×